Notices of Funding Opportunities
The table below lists all active NIDCR Notices of Funding Opportunitites (NOFOs). Use the filters to sort by funding type, topic, or activity code. Use the search box to find funding opportunities that include specific keywords. Click on title to see more details.
290 Results
| Title | Release Date | Expiration Date |
|---|---|---|
Notice of Intent to Publish a Funding Opportunity Announcement for Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed)
Contact:
Topics: Craniofacial & Dental Developmental Biology, Craniofacial Skeletal Biology & Pathobiology, Gene Discovery, Genomics & Multi-Omics Analysis |
||
Notice of Intent to Publish a Funding Opportunity Announcement for a Data Management and Coordinating Center for Diagnostic Centers of Excellence (U2C Clinical Trial Not Allowed)
Contact:
Topics: Craniofacial & Dental Developmental Biology, Craniofacial Skeletal Biology & Pathobiology, Gene Discovery, Genomics & Multi-Omics Analysis |
||
Notice of Information Reissuance of PA-18-932 Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) as a Notice of Special Interest (NOSI)
Contact:
Topics: Dissemination & Implementation Science, Epidemiology |
||
Notice of Clarification for PAR-19-164 "Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)"
|
||
Notice of Participation of the National Institute of Dental and Craniofacial Research (NIDCR) in RFA-MD-22-004 Innovations for Healthy LivingImproving Minority Health and Eliminating Health Disparities (R43/R44- Clinical Trial Optional)
|
||
Notice of Technical Assistance Webinar for RFA-AR-22-009, HEAL Initiative: Restoring Joint Health and Function to Reduce Pain Consortium (RE-JOIN)
Contact:
Topics: Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
||
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
The purpose of this engineering-oriented funding opportunity announcement (FOA) is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility. Contact:Topics: Oral, Oropharyngeal & Salivary Gland Cancers |
||
Notice to Extend Eligibility for Submission of Pathway to Independence Award Applications (K99/R00) to NIDCR due to Covid-19 disruptions
|
||
NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
|
||
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Basic Experimental Studies Involving Humans Required)
|
||
NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Basic Experimental Studies Involving Humans Required)
|
||
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Required)
|
||
NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
|
||
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)
|
||
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery and validation of novel therapeutic targets to facilitate the development of pain therapeutics. Specifically, the focus of this FOA is on the basic science discovery of targets in the peripheral nervous system, central nervous system, immune system or other tissues in the body that can be used to develop treatments that have minimal side effects and little to no abuse/addiction liability. Research supported by this FOA must include rigorous validation studies to demonstrate the robustness of the target as a pain treatment target. This will lower the risk of adopting the target in translational projects to develop small molecules, biologics, natural substances, or devices that interact with this target for new pain treatments. Translational research to develop new medical devices are not the focus of this FOA. Basic science studies of pain and related systems in the body are responsive to this FOA and are encouraged in the context of novel pain therapeutic target discovery. This FOA is not specific for any one or group of pain conditions. Projects to identify novel targets for acute pain, chronic pain, migraine, other headache disorders, osteoarthritis, diabetic neuropathy, chemotherapy-induced neuropathy, sickle-cell pain, post stroke pain, etc. will be considered. Projects to identify novel targets for a combination of chronic overlapping pain conditions or for specific pathological conditions will be considered. Projects that seek to identify novel targets in specific populations such as women, children, older adults or other underrepresented groups will also be responsive to this FOA. Contact:Topics: Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
||
Notice of Information: Multi-Institute Interest in Pain Research
Contact:
Topics: Clinical Research & Clinical Trials, Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
||
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Restoring Joint Health and Function to Reduce Pain Consortium (RE-JOIN) (UC2 Clinical Trial Not Allowed)
Contact:
Topics: Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
||
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Advancing Health Equity in Pain and Comorbidities (R61/R33 Clinical Trial Required)
Contact:
Topics: Oral Health Disparities & Inequities, Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
||
Notice of Intent to Publish a Funding Opportunity Announcement for NIH Neuroscience Doctoral Readiness Program (DR. Program) (R25 Clinical Trial Not Allowed)
|
||
Notice of Special Interest (NOSI): The Functional Oral Microbiome
|
||
Notice of Intent to Publish a Funding Opportunity Announcement for Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) FOA
|
||
Notice of Intent to Publish the "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15, Clinical Trial Required)" FOA
|
||
Notice of Special Interest: SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)
|
||
Reminder: FORMS-G Grant Application Forms & Instructions Must be Used for Due Dates On or After January 25, 2022 - New Grant Application Instructions Now Available
|
||
Notice to Extend Expiration Date for PAR-19-145 "NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03)
Contact:
Topics: Behavioral & Social Science, Craniofacial & Dental Developmental Biology, Craniofacial Skeletal Biology & Pathobiology, Dental Caries, Epidemiology, HIV/AIDS & Oral Health, Mucosal Diseases, Oral Health Disparities & Inequities, Oral, Oropharyngeal & Salivary Gland Cancers, Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology, Periodontal Diseases, Salivary Biology & Dysfunction |
||
Request for Information (RFI): Joint Pain and Innervation Research
Contact:
Topics: Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
||
Notice of Participation of the National Institute of Dental and Craniofacial Research (NIDCR) in PAR-21-287 Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional)
|
||
Notice of Special Interest (NOSI): Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities
|
||
NIDCR Guidance on Applications for Investigator-Initiated Clinical Trials
Contact:
Topics: Behavioral & Social Science, Clinical Research & Clinical Trials |
||
Updates to the Non-Discrimination Legal Requirements for NIH Recipients
|
||
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) hereby notify Small Business Concerns (SBCs) holding Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants that funds are available for administrative supplements to improve the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from groups that have been shown to be nationally underrepresented in health-related research or in the SBIR and STTR programs. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project. Administrative supplements must support work within the scope of the original project. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Contact:Topics: Small Business (SBIR/STTR) |
||
Notice of Intent to Publish a Funding Opportunity Announcement for NIH Blueprint for Neuroscience Research Short Courses in Neurotherapeutics Development (R25 Clinical Trial Not Allowed)
Contact:
Topics: Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
||
Notice of Special Interest (NOSI): Advancing Imaging, Device Production, and Clinical Capabilities in Digital Dentistry (R41/R42, R43/R44 Clinical Trial Not Allowed)
|
||
Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations
Contact:
Topics: Behavioral & Social Science, Dissemination & Implementation Science, Women's Health |
||
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
The purpose of the MOSAIC Postdoctoral Career Transition Award to Promote Diversity (K99/R00) program is to support a cohort of early career, independent investigators from diverse backgrounds conducting research in NIH mission areas. The long-term goal of this program is to enhance diversity in the basic biomedical sciences research workforce. The MOSAIC K99/R00 program is designed to facilitate a timely transition of outstanding postdoctoral researchers from diverse backgrounds (e.g., see NIHs Interest in Diversity) from their mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions at research-intensive institutions. The MOSAIC K99/R00 program will provide independent NIH research support during this transition to help awardees launch competitive, independent research careers. Additionally, MOSAIC K99/R00 scholars will be part of organized scientific cohorts that will be expected to participate in mentoring, networking, and professional development activities coordinated by MOSAIC Institutionally-Focused Research Education Award to Promote Diversity (UE5) grantees. Contact:Topics: Career Development, Research Training & Fellowships |
||
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Basic Experimental Studies with Humans Required (BESH))
The purpose of the MOSAIC Postdoctoral Career Transition Award to Promote Diversity (K99/R00) program is to support a cohort of early career, independent investigators from diverse backgrounds conducting research in NIH mission areas. The long-term goal of this program is to enhance diversity in the basic biomedical sciences research workforce. The MOSAIC K99/R00 program is designed to facilitate a timely transition of outstanding postdoctoral researchers from diverse backgrounds (e.g., see NIHs Interest in Diversity) from their mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions at research-intensive institutions. The MOSAIC K99/R00 program will provide independent NIH research support during this transition to help awardees launch competitive, independent research careers. Additionally, MOSAIC K99/R00 scholars will be part of organized scientific cohorts that will be expected to participate in mentoring, networking, and professional development activities coordinated by MOSAIC Institutionally-Focused Research Education Award to Promote Diversity (UE5) grantees. Contact:Topics: Career Development, Research Training & Fellowships |
||
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Required)
The purpose of the MOSAIC Postdoctoral Career Transition Award to Promote Diversity (K99/R00) program is to support a cohort of early career, independent investigators from diverse backgrounds conducting research in NIH mission areas. The long-term goal of this program is to enhance diversity in the basic biomedical sciences research workforce. The MOSAIC K99/R00 program is designed to facilitate a timely transition of outstanding postdoctoral researchers from diverse backgrounds (e.g., see NIHs Interest in Diversity) from their mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions at research-intensive institutions. The MOSAIC K99/R00 program will provide independent NIH research support during this transition to help awardees launch competitive, independent research careers. Additionally, MOSAIC K99/R00 scholars will be part of organized scientific cohorts that will be expected to participate in mentoring, networking, and professional development activities coordinated by MOSAIC Institutionally-Focused Research Education Award to Promote Diversity (UE5) grantees. Contact:Topics: Career Development, Research Training & Fellowships |
||
Notice of Special Interest (NOSI): Precision Imaging of Oral Lesions
|
||
Notice of Expiration of PAR-21-197, NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required).
|
||
Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional)
|
||
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management
Contact:
Topics: Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology, Technology Development |
||
Notice of Corrected Application Forms and Extended Receipt date for RFA-DE-22-002 Addressing Social Determinants of Health to Eliminate Oral Health Disparities (UG3/UH3 Clinical Trials Optional)
|
||
Notice of Correction to Application Types Allowed for PAR-21-197, NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Contact:
Topics: Behavioral & Social Science, Oral Health Disparities & Inequities |
||
Notice of NIDCR Participation in RFA-CA-21-035 The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)
|
||
Notice of NIDCR Participation in PAR-21-168, "Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)"
|
||
Notice of a Pre-Application Technical Assistance Webinar for NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00)
|
||
Notice of Early Termination of RFA-NS-21-016, HEAL Initiative: Planning Studies for Initial Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (R34 Clinical Trial Not Allowed)
Contact:
Topics: Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
||
Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint MedTech: Translator (UG3/UH3 Clinical Trial Optional)
Contact:
Topics: Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
||
Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Medtech: Small Business Translator (U44)
Contact:
Topics: Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology, Small Business (SBIR/STTR) |
||
Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint MedTech: Incubator Hubs (U54 Clinical Trial Not Allowed)
Contact:
Topics: Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
||
RESCINDED - Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint MedTech: Prototype Developer (U18 Clinical Trial Not Allowed)
Contact:
Topics: Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
||
Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed)
Rapid advances in genotyping and next generation sequencing technologies have led to the identification of genetic variants that are associated with a wide variety of congenital defects including structural birth defects (SBDs), intellectual developmental disabilities (IDDs) and inborn errors of metabolism (IEMs). Large quantities of genomic data collected from pediatric birth defects cohorts are available to the research community through several databases such as the Database of Genotypes and Phenotypes (dbGaP), the Gabriella Miller Kids First Data Resource Portal, the European Genome-Phenome Archive and Clinical Genome Resource (ClinGen). The purpose of this initiative is to promote the screening, functional validation and characterization of birth defects-associated genetic variants identified through public facing databases and individual efforts using in-silico tools, appropriate animal models, in vitro systems or multi-pronged approaches. This initiative addresses a challenging gap between identifying sequence variations of potential interest and recognizing which of those variations have functional effects on the phenotype of interest. Contact:Topics: Craniofacial & Dental Developmental Biology |
||
Continuation of Temporary Extension of Eligibility for the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00) During the COVID-19 Pandemic
|
||
Notice of Intent to Reissue PAR-18-847 Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01- Clinical Trial Optional) and PAR-18-848 (R21 - Clinical Trial Optional) as a Notice of Special Interest (NOSI)
Contact:
Topics: Oral, Oropharyngeal & Salivary Gland Cancers |
||
RESCINDED - NIDCR Policy on Applications for Investigator-Initiated Clinical Trials
Contact:
Topics: Behavioral & Social Science, Clinical Research & Clinical Trials |
||
Notice of Intent to Reissue PAR-18-845 Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed) and PAR-18-846 (R21 - Clinical Trial Not Allowed) as a Notice of Special Interest (NOSI)
|
||
Notice of Change to PAR-20-238, "Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)"
|
||
NIH Blueprint for Neuroscience Research: Request for Information (RFI) on Neuroimmune Interactions in the Healthy CNS
Topics: Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
||
Notice of Correction to R&R Budget Form for PAR-21-160, NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Contact:
Topics: Clinical Research & Clinical Trials |
||
Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
Topics: Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
||
Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Technology and Analytic Cores (TACs) and Research Management Unit (RMU) (UC2) (Clinical Trials Not Allowed)
Topics: Oral Immunology, Immunopathology & Immunotherapy |
||
Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
Topics: Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
||
Notice of Intent to Publish a Funding Opportunity Announcement for Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
Topics: Oral Health Disparities & Inequities |
||
HEAL Initiative: EPPIC-Net Pain Research Asset Application (OT2)
Contact:
Topics: Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
||
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Planning Studies for Initial Analgesic Development Initial Translational Efforts [Small Molecules and Biologics]
Topics: Parent Announcements & Trans-NIH Announcements, Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology |
||
Notice of Expiration of PAR-19-370 NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
|
||
Notice of NIH Participation in Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science
Topics: Bioinformatics, Computational Biology & Data Science |
||
Notice to Extend the Expiration Date for PAR-18-547, NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Topics: Clinical Research & Clinical Trials |
||
Notice to Extend the Expiration Date for PAR-18-656, NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
|
||
Notice of NIDCR's Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"
|
||
Notice of Change: Clarification of Budget for PA-20-227 "Administrative Supplements for Research on Dietary Supplements (Admin Supp Clinical Trial Not Allowed)"
Contact:
Topics: Behavioral & Social Science, COVID-19, Periodontal Diseases, Salivary Biology & Dysfunction, International Research Activities, Global Health, Fluoride & Fluorosis, Dental Materials & Biomaterials, Small Business (SBIR/STTR), Statistical Analysis & Data Science, Technology Development, Research Training & Fellowships, Common Fund Programs, Career Development, Mucosal Diseases, Tissue Engineering & Regenerative Medicine, Parent Announcements & Trans-NIH Announcements, Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology, Oral, Oropharyngeal & Salivary Gland Cancers, Oral Microbiology & Metagenomics, Oral Immunology, Immunopathology & Immunotherapy, Oral Health Disparities & Inequities, National Dental Practice-Based Research Network, Mineralized Tissues & Mineralization, Bioinformatics, Computational Biology & Data Science, Dental Caries, Clinical Research & Clinical Trials, Conferences & Meetings, Craniofacial & Dental Developmental Biology, Craniofacial Skeletal Biology & Pathobiology, Dissemination & Implementation Science, Epidemiology, Gene Discovery, Genomics & Multi-Omics Analysis, HIV/AIDS & Oral Health |
||
Notice of Additional Receipt Dates for PAR-20-073 National Dental Practice-Based Research Network Infrastructure Access (X01 Clinical Trial Not Allowed)
|
||
Notice of Change Regarding Institutional Eligibility for PAR-19-134 and PAR-19-135 "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools"
Contact:
Topics: Bioinformatics, Computational Biology & Data Science, Parent Announcements & Trans-NIH Announcements |
||
Notice of National Institute of Dental and Craniofacial Research (NIDCR) Participation in PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)
Contact:
Topics: Behavioral & Social Science, Periodontal Diseases, Salivary Biology & Dysfunction, Global Health, Fluoride & Fluorosis, Dental Materials & Biomaterials, Small Business (SBIR/STTR), Statistical Analysis & Data Science, Technology Development, Common Fund Programs, Mucosal Diseases, Tissue Engineering & Regenerative Medicine, Parent Announcements & Trans-NIH Announcements, Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology, Oral, Oropharyngeal & Salivary Gland Cancers, Oral Microbiology & Metagenomics, Oral Immunology, Immunopathology & Immunotherapy, Oral Health Disparities & Inequities, National Dental Practice-Based Research Network, Mineralized Tissues & Mineralization, Bioinformatics, Computational Biology & Data Science, Dental Caries, Clinical Research & Clinical Trials, Conferences & Meetings, Craniofacial & Dental Developmental Biology, Craniofacial Skeletal Biology & Pathobiology, Dissemination & Implementation Science, Epidemiology, Gene Discovery, Genomics & Multi-Omics Analysis, HIV/AIDS & Oral Health |
||
Notice of NIDCR Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
|
||
Notice of Change to salary allowance for K00 awardees for NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Independent Clinical Trial Not Allowed)
|
||
Notice to Update Eligibility for the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Independent Basic Experimental Studies with Humans Required) PAR-19-141
|
||
Notice of Clarification Relevant to Section IV, Application and Submission Information for PAR-20-045 NIDCR Research Grants for Analyses of Existing Genomics Data (R01 Clinical Trial Not Allowed)
|
||
Notice of Clarification Relevant to Section IV, Application and Submission Information for PAR-20-046 NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
Contact:
Topics: Bioinformatics, Computational Biology & Data Science, Statistical Analysis & Data Science |
||
Notice of NIDCR Participation in PAR-19-380 Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25)
|
||
Notice of Changes to NIDCR's Clinical Terms of Award (CToA) Policy
Contact:
Topics: Behavioral & Social Science, Periodontal Diseases, Salivary Biology & Dysfunction, International Research Activities, Global Health, Fluoride & Fluorosis, Dental Materials & Biomaterials, Small Business (SBIR/STTR), Statistical Analysis & Data Science, Technology Development, Research Training & Fellowships, Common Fund Programs, Career Development, Mucosal Diseases, Tissue Engineering & Regenerative Medicine, Parent Announcements & Trans-NIH Announcements, Orofacial Pain, Temporomandibular Joint Disorder & Neurobiology, Oral, Oropharyngeal & Salivary Gland Cancers, Oral Microbiology & Metagenomics, Oral Immunology, Immunopathology & Immunotherapy, Oral Health Disparities & Inequities, National Dental Practice-Based Research Network, Mineralized Tissues & Mineralization, Bioinformatics, Computational Biology & Data Science, Dental Caries, Clinical Research & Clinical Trials, Conferences & Meetings, Craniofacial & Dental Developmental Biology, Craniofacial Skeletal Biology & Pathobiology, Dissemination & Implementation Science, Epidemiology, Gene Discovery, Genomics & Multi-Omics Analysis, HIV/AIDS & Oral Health |
||
Notice to Extend the Expiration Date for PA-18-141 "Mechanisms, Models, Measurement, & Management in Pain Research (R01 Clinical Trial Optional)"
|
||
Notice of NIDCR's Participation in PAR-18-831 "The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed)"
|
||
Notice of NIDCR's Participation in PAR-18-830 "The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)"
|
||
Notice of NIDCR's Participation in PAR-19-194 "Microbial-based Cancer Therapy-Bugs as Drugs (R21- Clinical Trial Not Allowed)"
|
||
Notice of NIDCR's Participation in PAR-19-193 "Microbial-based Cancer Therapy-Bugs as Drugs (R01- Clinical Trial Not Allowed)"
|
||
Notice of Clarification of Award Budget for PAR-18-656 NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
|
||
Notice of Corrected Application Forms for PAR-18-547, NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Contact:
Topics: Clinical Research & Clinical Trials, Dissemination & Implementation Science |
||
Notice of NIDCR's participation in PAR-18-714, Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15-Clinical Trial Not Allowed)
|
||
Notice of Correction to PAR-18-656 "NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
|